For citations:
Isaev P.A., Semin D.Yu., Rumyantsev P.O., Il’in A.A., Pol’kin V.V., Agababyan T.A., Vasil’kov S.V., Medvedev V.S., Zhelonkina N.V. Clinical experience in using lenvatinib in patients with progressive, radioactive iodine-refractory differentiated thyroid cancer. Head and Neck Tumors (HNT). 2016;6(2):65-69. (In Russ.) https://doi.org/10.17650/2222-1468-2016-6-2-65-69
Email this article 